21 results on '"Qin, Yulin"'
Search Results
2. Bifunctional nanomaterial enabled high-specific isolation of urinary exosomes for cervical cancer metabolomics analysis and biomarker discovery
3. Online Learning to parallel offloading in heterogeneous wireless networks
4. An urban-scale method for building roofs available wind resource evaluation based on aerodynamic parameters of urban sublayer surfaces
5. Effect of diamond layer thickness on tool wear of polycrystalline diamond composites
6. High-pressure preparation of high-hardness CoCrFeNiMo0.4 high-entropy alloy
7. Chemical compositions and properties of lignin-based jet fuel range hydrocarbons
8. Treatment-naïve Gaucher disease patients achieve therapeutic goals and normalization with velaglucerase alfa by 4 years in phase 3 trials
9. Development of anti-velaglucerase alfa antibodies in clinical trial-treated patients with Gaucher disease
10. Modeling the development of vehicle lateral control skills in a cognitive architecture
11. An explanation of how the placement of traffic signs affects drivers’ deceleration on curves
12. Changes in the brain intrinsic organization in both on-task state and post-task resting state
13. fMRI study in posterior cingulate and adjacent precuneus cortex in healthy elderly adults using problem solving task
14. A central circuit of the mind
15. Information-processing modules and their relative modality specificity
16. Macrophage-Specific Expression of Human Lysosomal Acid Lipase Corrects Inflammation and Pathogenic Phenotypes in lal−/− Mice
17. Neutral Lipids and Peroxisome Proliferator-Activated Receptor-γ Control Pulmonary Gene Expression and Inflammation-Triggered Pathogenesis in Lysosomal Acid Lipase Knockout Mice
18. Response to request by journal editorship from Blood Cells, Molecules and Diseases in reference to a “Dear Editor” letter to the Pastores et al. paper, 2016
19. Therapeutic goals and normal clinical values achieved within 4 years of initiating velaglucerase alfa in treatment-naïve patients with Gaucher disease in phase 3 studies
20. Velaglucerase alfa enzyme replacement therapy in children and adolescents with type 3 Gaucher disease: Results of a 12-month multicenter, open-label phase 1/2 study
21. Effects of velaglucerase alfa on bone-related pathology in patients with type 1 Gaucher disease: Design and methods of a 2-year open-label phase 4 study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.